3Yan-Kui Chu,Yi Liu,Ji-Kai Yin,Nan Wang,Liang Cai,Jian-Guo Lu,Department of General Surgery,Tangdu Hospital, Fourth Military Medical University,Xi’an 710038,Shaanxi Province,China.Effect of mycophenolate mofetil plus adriamycin on HepG-2 cells[J].World Journal of Hepatology,2010,2(8):311-317. 被引量：1
4[3]Taylor-Robinson SD,Foster GR,Arora S,Hargreaves S,Thomas HC.Increase in primary liver cancer in the UK,1979-94.Lancet 1997; 350:1142-1143
5[4]Olthoff KM.Surgical options for hepatocellular carcinoma:resection and transplantation.Liver Transpl Surg 1998; 4:S98-S104
6[5]Iwatsuki S,Gordon RD,Shaw BW Jr,Starzl TE.Role of liver transplantation in cancer therapy.Ann Surg 1985; 202:401-407
7[6]O'Grady JG,Polson RJ,Rolles K,Calne RY,Williams R.Liver transplantation for malignant disease.Results in 93 consecutive patients.Ann Surg 1988; 207:373-379
8[7]Ringe B,Wittekind C,Bechstein WO,Bunzendahl H,Pichlmayr R.The role of liver transplantation in hepatobiliary malignancy.A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence.Ann Surg 1989; 209:88-98
9[8]Ismail T,Angrisani L,Gunson BK,Hubscher SG,Buckels JA,Neuberger JM,Elias E,McMaster P.Primary hepatic malignancy:the role of liver transplantation.Br J Surg 1990;77:983-987
10[9]Ringe B,Pichlmayr R,Wittekind C,Tusch G.Surgical treatment of hepatocellular carcinoma:experience with liver resection and transplantation in 198 patients.World J Surg 1991; 15:270-285
